Literature DB >> 8512063

Simultaneous preparation and quantitation of proteoglycans by precipitation with alcian blue.

S Björnsson1.   

Abstract

Conditions for specific interaction between Alcian blue and proteoglycans were optimized by comparing the differential spectra of Alcian blue obtained with purified chondroitin sulfate dissolved in water with the spectra obtained with nasal cartilage proteoglycans dissolved in synovial fluid. A method was then designed that provides specific precipitation of proteoglycans or glycosaminoglycans in 4 M guanidine - HCl in the presence of protein, hyaluronic acid, or nucleic acids. The specificity is achieved by using a low pH in combination with detergent and high salt concentration. Stepwise addition of reagents is necessary to avoid binding of Alcian blue to proteins and nucleic acids. All polyanions, except polysulfates, are first neutralized by lowering the pH to 1.5. By including detergent in this step, the hydrophobic protein regions are blocked and not accessible for binding with the dye. These regions could otherwise bind Alcian blue by hydrophobic interaction. When the Alcian blue reagent is added after, only the polysulfated molecules will remain charged and free to interact with Alcian blue. At least 0.4 M guanidine-HCl is required to abolish the negative interference by proteins. All sulfated glycosaminoglycans are precipitated at 0.4 M guanidine-HCl. With increasing guanidine-HCl concentrations, the different glycosaminoglycans are precipitated in accordance with the critical electrolyte concentration of the respective glycosaminoglycan. The Alcian blue precipitation can be performed at different concentrations of guanidine-HCl in order to separate different classes of proteoglycans. Excess dye and contaminating proteins are removed by a wash in a DMSO-MgCl2 solution and the precipitate is dissolved in a mixture of guanidine-HCl and propanol. For quantitation, the absorbance is recorded in a microplate reader with the 600-nm filter, the assay being linear between 0.5 and 20 micrograms proteoglycan. Since no digestion of samples with protease is needed, the proteoglycans are recovered in native form. The proteoglycan-Alcian blue complexes dissociate in the guanidine-HCl/propanol mixture and the proteoglycans can be selectively precipitated with propanol. The dye is used for quantitation and the proteoglycans can be utilized for further analysis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8512063     DOI: 10.1006/abio.1993.1197

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  60 in total

1.  Polymerization and matrix physical properties as important design considerations for soluble collagen formulations.

Authors:  S T Kreger; B J Bell; J Bailey; E Stites; J Kuske; B Waisner; S L Voytik-Harbin
Journal:  Biopolymers       Date:  2010-08       Impact factor: 2.505

2.  The Quantification of Glycosaminoglycans: A Comparison of HPLC, Carbazole, and Alcian Blue Methods.

Authors:  Sarah B Frazier; Kevin A Roodhouse; Dennis E Hourcade; Lijuan Zhang
Journal:  Open Glycosci       Date:  2008-01-01

3.  Influence of different commercial scaffolds on the in vitro differentiation of human mesenchymal stem cells to nucleus pulposus-like cells.

Authors:  Alessandro Bertolo; Marco Mehr; Niklaus Aebli; Martin Baur; Stephen J Ferguson; Jivko V Stoyanov
Journal:  Eur Spine J       Date:  2011-08-24       Impact factor: 3.134

4.  Increased differentiation capacity of bone marrow-derived mesenchymal stem cells in aquaporin-5 deficiency.

Authors:  Fei Yi; Muhammad Khan; Hongwen Gao; Feng Hao; Meiyan Sun; Lili Zhong; Changzheng Lu; Xuechao Feng; Tonghui Ma
Journal:  Stem Cells Dev       Date:  2012-04-20       Impact factor: 3.272

5.  Missense models [Gustm(E536A)Sly, Gustm(E536Q)Sly, and Gustm(L175F)Sly] of murine mucopolysaccharidosis type VII produced by targeted mutagenesis.

Authors:  Shunji Tomatsu; Koji O Orii; Carole Vogler; Jeffrey H Grubb; Elizabeth M Snella; Monica A Gutierrez; Tatiana Dieter; Kazuko Sukegawa; Tadao Orii; Naomi Kondo; William S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-28       Impact factor: 11.205

6.  Primary human chondrocyte extracellular matrix formation and phenotype maintenance using RGD-derivatized PEGDM hydrogels possessing a continuous Young's modulus gradient.

Authors:  Laura A Smith Callahan; Anna M Ganios; Erin P Childers; Scott D Weiner; Matthew L Becker
Journal:  Acta Biomater       Date:  2013-01-02       Impact factor: 8.947

7.  A model of mucopolysaccharidosis IIIB (Sanfilippo syndrome type IIIB): N-acetyl-alpha-D-glucosaminidase deficiency in Schipperke dogs.

Authors:  N M Ellinwood; P Wang; T Skeen; N J H Sharp; M Cesta; S Decker; N J Edwards; I Bublot; J N Thompson; W Bush; E Hardam; M E Haskins; U Giger
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

8.  Synovial reaction and concentrations of proteoglycan fragments in joint fluid after intraarticular knee injuries.

Authors:  K Messner; J Gao
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1995       Impact factor: 4.342

9.  Bone marrow transplantation for feline mucopolysaccharidosis I.

Authors:  N Matthew Ellinwood; Marie-Anne Colle; Margaret A Weil; Margret L Casal; Charles H Vite; Staci Wiemelt; Christopher W Hasson; Thomas M O'Malley; Xingxuan He; Ulana Prociuk; Lucie Verot; John R Melniczek; Anne Lannon; Gustavo D Aguirre; Van W Knox; Sydney M Evans; Marie T Vanier; Edward H Schuchman; Steven U Walkley; Mark E Haskins
Journal:  Mol Genet Metab       Date:  2007-05-07       Impact factor: 4.797

10.  Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study.

Authors:  Staffan Larsson; L Stefan Lohmander; André Struglics
Journal:  Arthritis Res Ther       Date:  2009-06-22       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.